核医学基础和临床：PET/CT与PET/MR分子影像
Basic and Clinical Practice of Nuclear Medicine: PET/CT and PET/MR Molecular Imaging
同济大学附属东方医院核医学科主任、诊断学总教研室主任兼核医学教研室主任、心血管影像中心主任、中华医学会核医学分会常委兼PET学组组长（2023-至今、2011-2018）、肿瘤学组组长（2018-2023）、PET/MR工作委员会副主任委员（2015-至今）、中国核学会核医学分会副理事长、上海医学会核医学专委会副主任委员、上海医师协会核医学医师分会副会长。中华核医学与分子影像杂志常务编委、国际放射医学核医学杂志副主编等
Director of Department of the Nuclear Medicine, Director of the General Teaching and Research Office of Diagnostic Medicine and Nuclear Medicine, Director of the Cardiovascular Imaging Center
Standing Committee Member of the Nuclear Medicine Branch of Chinese Medical Association and Head of the PET Group (2023 present, 2011-2018), Head of the Oncology Group (2018-2023), Vice Chairman of the PET/MR Working Committee (2015 present), Vice Chairman of the Nuclear Medicine Branch of the Chinese Nuclear Society, Vice Chairman of the Nuclear Medicine Special Committee of the Shanghai Medical Association, Vice Chairman of the Nuclear Medicine Physician Branch of the Shanghai Medical Doctor Association. Executive Editorial Board Member of the Chinese Journal of Nuclear Medicine and Molecular Imaging, and Deputy Editor in Chief of the International Journal of Radiological Medicine and Nuclear Medicine
1995年开始从事PET临床应用研究工作，第1作者及通讯作者发表SCI及核心期刊论文80余篇。承担国家自然科学基金面上项目3项、上海市科委及国际原子能机构科研课题。获得中华医学科技奖三等奖及教育部科学技术进步奖二等奖等。组织和参与编写中华医学会核医学分会PET技术操作规范和临床应用指南。参编国家药典临床用药须知2010、2015及2020版。参加人民卫生出版社《核医学》八年制及研究生教材编写。主持国家级继续教育项目培训班14期。
In 1995, Dr. Zhao Jun began to engage in PET clinical application and research. More than 80 papers in SCI and core journals were published by first author and corresponding author. He has received 3 general projects of National Science Foundation of China (NSFC), and other grants from Science and Technology Commission of Shanghai Municipality and IAEA. He won the third prize of Chinese Medical Association science and technology Award and the second prize of science and technology progress award of the Ministry of Education. He organized and/or participated in PET technical specification and clinical application guidelines of CSNM. He participated in the compilation of the Clinical Guide to the Chinese Pharmacopoeia 2010, 2015 and 2020. He participated in the eight-year program and postgraduate Nuclear Medicine Textbook published by the People’s Medical Publishing House.
